Marc Bosiers

Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length

Hans Krankenberg, Michael Schlüter, Hermann Steinkamp et al. · Circulation · 2007 · 508 citations · Full text

<b>Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery:</b>Long-term Results From the SIROCCO Trial

Stephan H. Duda, Marc Bosiers, Johannes Lämmer et al. · Journal of Endovascular Therapy · 2006 · 491 citations

Drug‐Eluting Bioabsorbable Magnesium Stent

Carlo Di Mario, H. Griffiths, Ömer Göktekín et al. · Journal of Interventional Cardiology · 2004 · 424 citations

Tissue Engineering, Engineering, Current Stent Technology +14

Sirolimus-Eluting versus Bare Nitinol Stent for Obstructive Superficial Femoral Artery Disease: The SIROCCO II Trial

Stephan H. Duda, Marc Bosiers, Johannes Lämmer et al. · Journal of Vascular and Interventional Radiology · 2005 · 407 citations

Sirocco Ii Trial, Endovascular Technique, Cardiovascular Disease +8

The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Femoropopliteal Revascularization

Dierk Scheinert, Stephan H. Duda, Thomas Zeller et al. · JACC: Cardiovascular Interventions · 2014 · 388 citations

Vascular Surgery, Reconstructive Surgery, Surgery +5